FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On November 20, 2006
Docket # Title
1976N-0052N OTC Nasal Decongestants
1978N-0065 Skin Bleaching Drug Products
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
2002P-0317 Recall Aspartame as a Neurotoxic Drug
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
2004P-0349 Action on Products containing added Mercury
2004P-0528 ANDA suitability for preoperative prep containing a chlorhexidine gluconate (CHG)/isopropol alcohol (IPA) solution with tint
2005N-0413 Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments
2005N-0444 Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Dandruff Control Ingredient
2005P-0204 deny the pre-market approval applications of Mentor Corporation and Inamed Corporation for approval of silicone-gel filled breast implant products
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006D-0303 Guidance for Industry on Public Availability of Labeling Changes in Changes Being Effected Supplements
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
2006D-0336 Guidance for Industry and Food and Drug Administration Staff; Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
2006N-0107 FDA-Regulated Products Containing Nanotechnology Materials
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006N-0414 Suicidality Data from Adult Antidepressant Trials
2006P-0085 To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
2006P-0209 Safety or Efficacy of Diastat (diazepam rectal gel), 5 mg/ml, 10mg/2 ml, 15 mg/3 ml and 20 mg/4 ml
2006P-0361 Deny Request to switch ketotifen fumarate ophthalmic solution, 0.025%
2006P-0392 Refrain from approving any ANDA for a Diazepam Rectal Gel that Relies on Diastat
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2006P-0415 Petition Seeking Regulation of Cloned Animals
2006P-0469 Declare that a new drug application for Ibuprofen Potassium 200 mg Phenylephine Hydrochloride 10 mg Capsules is suitable for submission as an Abbreviated New Drug Application, pursuant to 21 CFR 314.9
2006P-0471 Issue standards and regulations to help ensure the safe productions of fresh fruits and vegetable
2006V-0470 Laser Light Show Projector
1976N-0052N OTC Nasal Decongestants
EMC 140 WYETH CONSUMER HEALTHCARE Vol #: 106
1978N-0065 Skin Bleaching Drug Products
EC 73 Dr. Amit Pandya Vol #: 14
EC 74 Dr. Gina Ang Vol #: 14
EC 75 Key Laser Institute for Aesthetic Medicine Vol #: 14
EC 76 Leonard J. Swinyer, M.D., P.C. Vol #: 14
EC 77 Dr. Bernard Burton Vol #: 14
EC 78 Dr. Diane Bernardi Vol #: 14
EC 79 Belle Meade Dermatology Vol #: 14
EC 80 American Society for Dermatological Surgery Vol #: 14
EC 81 American Osteopathic College of Dermatology Vol #: 14
EC 82 Accent Dermatology and Laser Institute Vol #: 14
EC 83 Dr. cindy hoffman Vol #: 14
EMC 3 F. D'Alessandro Vol #: 4
2001P-0230 Domestic Marketing & Importation of Transgenic Fish
C 1396 G. Caughlan Vol #: 259
2002P-0317 Recall Aspartame as a Neurotoxic Drug
EMC 739 V. Inness-Brown Vol #: 10
EMC 740 D. Fleming Vol #: 10
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1382 D. Garcia Vol #: 12
EMC 1383 L. Edan Vol #: 12
EMC 1384 P. Langevin Vol #: 12
2003N-0312 Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
EC 27 Dr. Nondas Bellos Vol #: 8
EC 28 Marcelo Ricci Uvinha Vol #: 8
2004P-0349 Action on Products containing added Mercury
EC 26 Ms. Betty Wireman Vol #: 4
2004P-0528 ANDA suitability for preoperative prep containing a chlorhexidine gluconate (CHG)/isopropol alcohol (IPA) solution with tint
WDL 1 Cardinal Health Vol #: 1
2005N-0413 Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments
EMC 11 C. Paugh Vol #: 2
2005N-0444 Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Dandruff Control Ingredient
SUP 1 Procter & Gamble Vol #: 4
2005P-0204 deny the pre-market approval applications of Mentor Corporation and Inamed Corporation for approval of silicone-gel filled breast implant products
PDN 1 FDA/CDRH to Zuckerman Spaeder LLP Vol #: 1
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18211 L. Arnold Vol #: 198
C 18212 T. Luedeman Vol #: 198
EMC 4113 D. Burton Vol #: 195
EMC 4114 N. Snow Vol #: 195
EMC 4115 K. Peterson Vol #: 195
EMC 4116 R. Bolduc Vol #: 195
EMC 4117 K. Gray Vol #: 195
EMC 4118 D. Ferguson Vol #: 195
EMC 4119 W. Card Vol #: 195
EMC 4120 J. Sloan Vol #: 195
EMC 4121 A. Woods Vol #: 195
EMC 4122 C. Roberts Vol #: 195
EMC 4123 P. Horton Vol #: 195
EMC 4124 C. Shade Vol #: 195
EMC 4125 M. Conklin Vol #: 195
2006D-0303 Guidance for Industry on Public Availability of Labeling Changes in Changes Being Effected Supplements
C 2 Sanofi-Synthelabo, Inc. and Aventis Pharmaceuticals Vol #: 1
C 3 Genzyme Corporation Vol #: 1
C 4 Genentech, Inc. Vol #: 1
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
EC 56 The Cato Institute Vol #: 3
EC 57 Quintiles Transnational Corp. Vol #: 3
2006D-0336 Guidance for Industry and Food and Drug Administration Staff; Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions
C 2 Nanogen, Inc. Vol #: 1
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
C 81 M. Tillman, J.D. Vol #: 7
C 82 B. Mormando Vol #: 7
C 83 E. Heaney Vol #: 7
C 84 M. Palmieri Vol #: 7
C 85 R. Soucy Vol #: 7
C 86 C. Brown Vol #: 7
C 87 Y. Tenorio Vol #: 7
C 88 P. Cummings Vol #: 7
C 89 S. Galligan Vol #: 7
C 90 E. Brunkhorst, RN Vol #: 7
C 91 S. Milam Vol #: 7
C 92 J. Lynch Vol #: 7
C 93 H. Leonard Vol #: 7
C 94 M. Miller Vol #: 7
C 95 M. Jude C.P. Vol #: 7
C 96 D. Neal Vol #: 7
C 97 P. Miller Vol #: 7
C 98 A. Scheett Vol #: 7
C 99 S and D McEnery Vol #: 7
C 100 S. and D. McEnry Vol #: 7
C 101 K. Fucci Vol #: 7
C 102 M. O'Donnell Vol #: 7
C 103 L. Kozlowski, M.D. Vol #: 7
C 104 S. Shambro Vol #: 7
C 105 M. Palmieri Vol #: 7
C 106 B. Shambro Vol #: 7
EC 1891 Mrs. Michelle Carner Vol #: 8
EC 1892 Mr. Kevin O'Brien Vol #: 8
EC 1893 Ms. Meaghan Dalferro Vol #: 8
EC 1894 Dr. Paul Bauer Vol #: 8
EC 1895 Dr. Peter Jahnke Vol #: 8
EC 1896 Mrs. Jane Cops Vol #: 8
EC 1897 Mr. Gerry Hatcher Vol #: 8
EC 1898 SEM Publishing Vol #: 8
EC 1899 Mrs. Geraldine Comeau Vol #: 8
EC 1900 Mr. David Reeves Vol #: 8
EC 1901 Miss. Leah Ghazal Vol #: 8
EC 1902 University of Wisconsin Medical School Vol #: 8
EC 1903 Mrs. J McCarthy Vol #: 8
EC 1904 Mrs. Fidelis Lindner Vol #: 8
EC 1905 US Oncology Vol #: 8
EC 1906 Individual Consumer Vol #: 8
EC 1907 Dr. Tim Lichter Vol #: 8
EC 1908 Mr. J Neil Schunke Vol #: 8
EC 1909 Mrs. Marcia Towle Vol #: 8
EC 1910 Mrs. Elizabeth Larson Vol #: 8
EC 1911 Mrs. Lauretta Taylor Vol #: 8
EC 1912 Mr. Michael Puljic Vol #: 8
EC 1913 Ms. Candice Botner Vol #: 8
EC 1914 Mrs. Joy Schoenberger Vol #: 8
EC 1915 Mrs. Rebecca Kirchberg Vol #: 8
EC 1916 Mr. Steve Beren Vol #: 8
EC 1917 Mr. Joel Willmarth Vol #: 8
EC 1918 Mrs. Abbie Risteen Vol #: 8
EC 1919 Miss. Lynne Shea Vol #: 8
EC 1920 Mr. Craig Gilbert Vol #: 8
EC 1921 Ms. Sarah Wilkinson Vol #: 8
EC 1922 Mr. Lloyd and Faie Duplantis Vol #: 8
EC 1923 Ms. Mary Zaeske-Weltzer Vol #: 8
EC 1924 Mrs. Nancy McCafferty Vol #: 8
EC 1925 Mrs. Luci Hannegan Vol #: 8
EC 1926 Mrs. Linda Stone Vol #: 8
EC 1927 Mrs. Bobi Beth Kallenbach Vol #: 8
EC 1928 Mr. Jeff Gura Vol #: 8
EC 1929 Human Life Council Vol #: 8
EC 1930 Mr. Ronald Storts Vol #: 8
EC 1931 Mrs. Norma Peters Vol #: 8
EC 1932 Ms. Joan Angevine Vol #: 8
EC 1933 Mr. Samuel Dean Vol #: 8
EC 1934 Mrs. Erin Rapp Vol #: 8
EC 1935 self Vol #: 8
EC 1936 Mrs. Pamela Brindley Vol #: 8
EC 1937 Ms. K. Gilson Vol #: 8
EC 1938 Mr. Eric Soiu Vol #: 8
EC 1939 Ms. Ashley Albers Vol #: 8
EC 1940 Mrs. Christine Potter Vol #: 8
EC 1941 Mrs. Christie Sherwood Vol #: 8
EC 1942 Mrs. Louise Juliano Vol #: 8
EC 1943 Mrs. Christine D'Angelo Vol #: 8
EC 1944 Mrs. Maura Butler Vol #: 8
EC 1945 Ms. Elizabeth Marie Peters Vol #: 8
EC 1946 Ms. Diane Bond Vol #: 8
EC 1947 Dr. Michele Yi Vol #: 8
EC 1948 Mrs. cynthia duvall Vol #: 8
EC 1949 Mrs. Jeanne Krien Vol #: 8
EC 1950 St. Mary's Community Hospital Vol #: 8
EC 1951 Ms. mary hesse Vol #: 8
EC 1952 Ms. Lillian Thompson Vol #: 8
EC 1953 Mr. Donald Patrich Vol #: 8
EC 1954 Mr. David Barker Vol #: 8
EC 1955 Miss. Hanna Miecznikowski Vol #: 8
EC 1956 Mr. William Werner Vol #: 8
EC 1957 Mrs. Anita Usher Vol #: 8
EC 1958 Ms. susan loftis Vol #: 8
EC 1959 Mrs. Regina Michael Vol #: 8
EC 1960 Mrs. Margaret Stender Vol #: 8
EC 1961 Mrs. Juliana Gonzalez Vol #: 8
EC 1962 Mr. Jarl Renn Vol #: 8
EC 1963 Mr. Joseph Bruce Vol #: 8
EC 1964 Mr. Patrick O'Hearn Vol #: 8
EC 1965 Mr. Simon Penhalagan Vol #: 8
EC 1966 Mrs. Sharon Widman Vol #: 8
EC 1967 Mr. David Dufresne Vol #: 8
EC 1968 Ms. Suzanne Rider Vol #: 8
EC 1969 Mr. nat parisi Vol #: 8
EC 1970 Ms. Daun Dunlap Vol #: 8
EC 1971 Mrs. Jean Gaes Vol #: 8
EC 1972 Mr. Bob Pikul Vol #: 8
EC 1973 NIH Vol #: 8
EC 1974 Mrs. Jean Troop Vol #: 8
EC 1975 Mrs. denise lynch Vol #: 8
EC 1976 Mr. Brian Gomolski Vol #: 8
EC 1977 Mr. Theodore Johnson Vol #: 8
EC 1978 Mrs. Lori Sims Vol #: 8
EC 1979 Mr. John Martino Vol #: 8
EC 1980 Mr. Bob Williams Vol #: 8
EC 1981 Mrs. Gretchen Malovoz Vol #: 8
EC 1982 Mrs. Kathleen Rahe Vol #: 8
EC 1983 Mrs. Jackie Lagemaat Vol #: 8
EC 1984 Mrs. Arielle Kurtze Vol #: 8
2006N-0107 FDA-Regulated Products Containing Nanotechnology Materials
C 16 K. Miller Vol #: 15
C 17 American Association of Orthopaedic Surgeons (AAOS) Vol #: 15
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
C 160 F. Nelson Vol #: 25
C 161 S. Kreider, MSIT, RN, CPC Vol #: 25
C 162 P. Caruso Vol #: 25
C 163 D. Pohlman Vol #: 25
C 164 Mercury Policy Project/Tides Center Vol #: 25
C 165 K. Fitzpatrick Vol #: 25
C 166 B. Barewald, R.N. Vol #: 25
C 167 H. Jankowski Vol #: 25
C 168 R. Murray Vol #: 25
C 169 A. Rust, DMD, MPA Vol #: 25
C 170 N. Ottawa Vol #: 25
C 171 M. Long, RN Vol #: 25
C 172 Fluoride Action Network Vol #: 25
C 173 Green Delaware Vol #: 25
C 174 L. Griffin Vol #: 25
C 175 T. Robson, D.C. Vol #: 25
C 176 K. Moore Vol #: 25
C 177 G. Taylor Vol #: 25
C 178 D and J Horner Vol #: 25
C 179 S. Friedman, D.C. Vol #: 25
C 180 D. Olah, DMD Vol #: 25
C 181 F. DDS Vol #: 25
C 182 R. Bianchi Vol #: 25
C 183 A. Gruber Vol #: 25
C 184 M. Norman Vol #: 25
C 185 B. Albrecht Vol #: 25
C 186 G. Herring Vol #: 25
C 187 C. Petersen Vol #: 25
C 188 G. Cole, DDS Vol #: 25
C 189 H. Hall Vol #: 25
C 190 C. Hallet Vol #: 25
C 191 E. Krinsky Vol #: 25
C 192 E. Birlem Vol #: 25
C 193 J. Stuart Vol #: 25
C 194 R. McCully Vol #: 25
C 195 S. Dicks, DC Vol #: 25
C 196 N. Flack Vol #: 25
C 197 P. Momsen Vol #: 25
C 198 L. Thomas Vol #: 25
C 199 D. Martin Vol #: 25
C 200 T. Kruzen Vol #: 25
C 201 Consumers for Dental Choice Vol #: 25
C 202 T. Conroy Vol #: 25
C 203 D. Kaiser Vol #: 25
C 204 K. Huttleston Vol #: 25
C 205 A. Marcyoniak Vol #: 25
C 206 M. Ehrech Vol #: 25
C 207 T. McIlvaine Vol #: 25
C 208 Y. Tal Vol #: 25
C 209 R. LaVlgne Vol #: 25
C 210 S. Marad Vol #: 25
C 211 No signature Vol #: 25
C 212 T. Osmanski Vol #: 25
C 213 A. Muhlberg Vol #: 25
C 214 D. Dorsey Vol #: 25
C 215 D. Borzini Vol #: 25
C 216 W. Overfelt Vol #: 25
C 217 L. Crosby Vol #: 25
C 218 P. Grimsley Vol #: 25
C 219 C. Andros Vol #: 25
C 220 L. Adams Vol #: 25
C 221 J. Riggs Vol #: 25
C 222 A. Cusick Vol #: 25
C 223 A. Castellano Vol #: 25
C 224 No signature Vol #: 25
C 225 M. Brandt Vol #: 25
C 226 K. Wolfram Vol #: 25
C 227 K. Buck Vol #: 25
C 228 T. Patton, LMBT Vol #: 25
C 229 D. Boone Vol #: 25
C 230 L. Adams Vol #: 25
C 231 K. Kaiser Vol #: 25
C 232 R. Davis Vol #: 25
C 233 J. Wanner Vol #: 25
C 234 M. Bernstein, M.D., M.S., J.D. Vol #: 25
C 235 J. Marich Vol #: 25
C 236 N. Barnhart Vol #: 25
C 237 S. Gwinn Vol #: 25
C 238 J. Washick Vol #: 25
C 239 N. Kwiatkowski Vol #: 25
C 240 D. Sluis Vol #: 25
C 241 A. Jacobson, PhD Vol #: 25
C 242 J. Miller Vol #: 25
C 243 O. Duke Vol #: 25
C 244 J. Sachs Vol #: 25
C 245 D. Peterson Vol #: 25
C 246 R. Nelson Vol #: 25
C 247 No signature Vol #: 25
C 248 K. Peterson, DCND Vol #: 25
C 249 J. Warren Vol #: 25
C 250 G. Odgers Vol #: 25
C 251 Carbondale City Council Vol #: 25
C 252 E. McDonagh BSc Vol #: 25
C 253 P. Owen Vol #: 25
C 254 V. Nolan Vol #: 25
C 255 V. Dong Vol #: 25
C 256 K. Morris Vol #: 25
C 257 T. Johnson Vol #: 25
C 258 K. Newman Vol #: 25
C 259 R. Kerger Vol #: 25
C 260 R and R Foreman Vol #: 25
C 261 E. Krinsky Vol #: 25
C 262 N. Call Vol #: 25
C 263 L. Cifelli Vol #: 25
C 264 N. Coenen Vol #: 25
C 265 K. Burns Vol #: 25
C 266 McBride Enterorises, Inc. Vol #: 25
C 267 B. Mather Vol #: 25
C 268 N. Call Vol #: 25
C 269 Dr. M. Young Vol #: 25
C 270 I. Lawrence Vol #: 25
C 271 J. Abdu Vol #: 25
C 272 Linda S. Vol #: 25
C 273 D. Eheman Vol #: 25
C 274 D. Robbins, DMD, FAGD Vol #: 25
C 275 D. Mariano Vol #: 25
C 276 C. Leavitt Vol #: 25
C 277 M. Graven Vol #: 25
2006N-0414 Suicidality Data from Adult Antidepressant Trials
EMC 1 H. Patenaude Vol #: 2
2006P-0085 To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
C 4 Nobbe Orthopedics, Inc. Vol #: 1
EC 5 AANS/CNS Joint Section for Pediatric Neurosurgery Vol #: 1
2006P-0209 Safety or Efficacy of Diastat (diazepam rectal gel), 5 mg/ml, 10mg/2 ml, 15 mg/3 ml and 20 mg/4 ml
C 4 Valeant Pharmaceuticals International (Valeant) Vol #: 1
LET 1 FDA/CDER to Lachman Consultant Services, Inc. Vol #: 1
2006P-0361 Deny Request to switch ketotifen fumarate ophthalmic solution, 0.025%
WDL 1 Rakoczy Molino Mazzochi Siwik, LLP Vol #: 1
2006P-0392 Refrain from approving any ANDA for a Diazepam Rectal Gel that Relies on Diastat
C 1 Valeant Pharmaceuticals International (Valeant) Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
EC 415 Mr. Jack Guthrie Vol #: 7
2006P-0415 Petition Seeking Regulation of Cloned Animals
EC 2 Ms. Betty Wireman Vol #: 2
2006P-0469 Declare that a new drug application for Ibuprofen Potassium 200 mg Phenylephine Hydrochloride 10 mg Capsules is suitable for submission as an Abbreviated New Drug
Application, pursuant to 21 CFR 314.9
ACK 1 FDA/DDM to Strides Inc. Vol #: 1
CP 1 Strides Inc. Vol #: 1
2006P-0471 Issue standards and regulations to help ensure the safe productions of fresh fruits and vegetable
ACK 1 FDA/DDM to Center for Science in the Public Interest Vol #: 1
CP 1 Center for Science in the Public Interest Vol #: 1
2006V-0470 Laser Light Show Projector
ACK 1 Club MO Lasers Vol #: 1
VAR 1 Club MO Lasers Vol #: 1

Page created on November 21, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management